scholarly journals The Use of Impression Cytology in Ocular Surface Diseases

2019 ◽  
Vol 1 (35) ◽  
pp. 43-46 ◽  
Author(s):  
Gulay Turan ◽  
Pembe Oltulu ◽  
Meydan Turan ◽  
Refik Oltulu
2020 ◽  
pp. 112067212093209
Author(s):  
Seyed Mohamadmehdi Moshtaghion ◽  
Mohammad Abolhosseini ◽  
Mozhgan Rezaei Kanavi ◽  
Seyed Bagher Hosseini ◽  
Mahnoush Rezaei Kanavi

Purpose: Investigating impression cytology (IC) results of various types of clinically suspected ocular surface lesions over a 14-year period in a referral center in Iran. Methods: IC findings obtained from patients with different types of ocular surface disorders between 2005 and 2018 were reviewed. Agreement between clinical suspicions and IC results was evaluated by calculating Cohen’s Kappa coefficient (CKC). Results: Clinical suspicions in 688 surveyed eyes were ocular surface squamous neoplasia (OSSN, 42.0%), limbal stem cell deficiency (LSCD, 36.3%), dry eye-related disorders (DERD, 11.5%), Acanthamoeba keratitis (AK, 7.2%), benign pigmented lesions (BPL, 1.9%), immune-related conjunctivitis (IRC, 0.7%), and malignant pigmented lesions (MPL, 0.4%). General agreement between clinical suspicions and IC results was 0.68 for all groups. This agreement was almost perfect in AK (CKC = 0.966) and BPLs (CKC = 0.843), and was substantial in MPLs (CKC = 0.749), OSSNs (CKC = 0.684), and LSCD (CKC = 0.612). CKC in IRC (0.567) and DERDs (0.443) was moderate. Histopathologic results were available in 22 eyes and were well-correlated with corresponding IC results (CKC = 0.86). Multiple post-treatment follow-up sessions of IC were performed in 51 eyes (11.4%) that had diagnosis of LSCD (31), OSSN (17), and MPL (3) at the first IC session. Conclusion: Our survey not only demonstrated an overall substantial agreement between IC results and primary clinical suspicions, but also showed an almost perfect correlation between IC results and existent histopathologic data. Therefore, IC as a non-invasive diagnostic modality can be of great importance in proper diagnosis of various ocular surface diseases especially when distinguishing malignant from benign lesions is required.


2018 ◽  
Vol 167 ◽  
pp. 31-43 ◽  
Author(s):  
Javier Soria ◽  
Arantxa Acera ◽  
Juan A. Durán ◽  
Ana Boto-de-los-Bueis ◽  
Almudena Del-Hierro-Zarzuelo ◽  
...  

Medicines ◽  
2021 ◽  
Vol 8 (2) ◽  
pp. 12
Author(s):  
Arianna A. Tovar ◽  
Ian A. White ◽  
Alfonso L. Sabater

Blood derived products have become a valuable source of tissue for the treatment of ocular surface diseases that are refractory to conventional treatments. These can be obtained from autologous or allogeneic sources (patient’s own blood or from healthy adult donors/umbilical cord blood, respectively). Allogeneic cord blood demonstrates practical advantages over alternatives and these advantages will be discussed herein. Umbilical cord blood (UCB) can be divided, generally speaking, into two distinct products: first, mononuclear cells, which can be used in regenerative ophthalmology, and second, the plasma/serum (an acellular fraction), which may be used in the form of eyedrops administered directly to the damaged ocular surface. The rationale for using umbilical cord serum (UCS) to treat ocular surface diseases such as severe dry eye syndrome (DES), persistent epithelial defects (PED), recurrent epithelial erosions, ocular chemical burns, graft versus host disease (GVHD), among others, is the considerably high concentration of growth factors and cytokines, mimicking the natural healing properties of human tears. Allogeneic serum also offers the opportunity for therapeutic treatment to patients who, due to poor heath, cannot provide autologous serum. The mechanism of action involves the stimulation of endogenous cellular proliferation, differentiation and maturation, which is highly efficient in promoting and enhancing corneal epithelial healing where other therapies have previously failed.


Author(s):  
Noelia Sabater-Cruz ◽  
◽  
Marc Figueras-Roca ◽  
Miriam Ferrán-Fuertes ◽  
Elba Agustí ◽  
...  

2014 ◽  
Vol 25 (4) ◽  
pp. 264-269 ◽  
Author(s):  
Debora Garcia-Zalisnak ◽  
David Nash ◽  
Elizabeth Yeu

2021 ◽  
pp. 108827
Author(s):  
Adam Master ◽  
Wei Huang ◽  
Liqun Huang ◽  
Wenyi Li ◽  
Sait Saglam ◽  
...  

2019 ◽  
Vol 198 ◽  
pp. 257-264 ◽  
Author(s):  
Arooj Ashraf ◽  
Aleem Butt ◽  
Imran Khalid ◽  
Rao Umair Alam ◽  
Sajid Rashid Ahmad

Sign in / Sign up

Export Citation Format

Share Document